Dr. Ronald Roth, MD

NPI: 1013105253
Total Payments
$1,071
2024 Payments
$18.24
Companies
10
Transactions
13
Medicare Patients
3,856
Medicare Billing
$452,556

Payment Breakdown by Category

Food & Beverage$1,071 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,071 13 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $206.25 2 $0 (2017)
Gilead Sciences, Inc. $198.00 2 $0 (2019)
Allergan Inc. $180.28 2 $0 (2018)
Celgene Corporation $137.89 1 $0 (2017)
Amgen Inc. $99.00 1 $0 (2018)
PFIZER INC. $99.00 1 $0 (2019)
Medtronic Vascular, Inc. $56.30 1 $0 (2019)
Egalet US Inc $40.80 1 $0 (2017)
Pernix Therapeutics Holdings, Inc. $34.93 1 $0 (2017)
Exact Sciences Corporation $18.24 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $18.24 1 Exact Sciences Corporation ($18.24)
2019 $254.30 3 Gilead Sciences, Inc. ($99.00)
2018 $282.77 3 Amgen Inc. ($99.00)
2017 $515.38 6 Janssen Pharmaceuticals, Inc ($206.25)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/30/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $18.24 General
Category: Oncology
11/12/2019 Medtronic Vascular, Inc. Reveal LINQ (Device) Food and Beverage In-kind items and services $56.30 General
Category: Cardiac Diagnostics and Monitoring
09/10/2019 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $99.00 General
Category: HCV
05/14/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $99.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/13/2018 Amgen Inc. Prolia (Biological) Food and Beverage In-kind items and services $99.00 General
Category: Endocrinology
05/08/2018 Allergan Inc. AVYCAZ (Drug) Food and Beverage In-kind items and services $84.77 General
Category: ANTI-INFECTIVE
03/13/2018 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $99.00 General
Category: HCV
07/27/2017 Celgene Corporation GED-0301 (Drug) Food and Beverage In-kind items and services $137.89 General
07/11/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $119.36 General
Category: Cardiovascular & Metabolism
05/09/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $86.89 General
Category: Cardiovascular & Metabolism
04/10/2017 Allergan Inc. BYVALSON (Drug), BYSTOLIC Food and Beverage In-kind items and services $95.51 General
Category: CARDIOVASCULAR
02/25/2017 Egalet US Inc SPRIX (Drug) Food and Beverage In-kind items and services $40.80 General
Category: Pain Medicine
02/25/2017 Pernix Therapeutics Holdings, Inc. ZOHYDRO ER (Drug) Food and Beverage In-kind items and services $34.93 General
Category: PAIN

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 967 1,069 $468,635 $114,865
2022 11 921 1,024 $443,545 $110,599
2021 10 950 1,086 $457,710 $118,471
2020 11 1,018 1,194 $465,470 $108,621
Total Patients
3,856
Total Services
4,373
Medicare Billing
$452,556
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 169 169 $55,770 $20,984 37.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 202 237 $130,350 $19,251 14.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 184 244 $35,380 $16,627 47.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 97 98 $83,300 $14,243 17.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 129 135 $28,350 $13,061 46.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 42 42 $17,010 $6,971 41.0%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 48 48 $38,400 $6,701 17.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 35 35 $28,000 $6,216 22.2%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 26 26 $20,800 $4,766 22.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 20 20 $27,000 $3,948 14.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 15 15 $4,275 $2,097 49.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 223 260 $143,000 $23,155 16.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 143 143 $47,190 $18,620 39.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 193 253 $36,685 $17,249 47.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 101 102 $86,700 $15,177 17.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 110 115 $24,150 $11,446 47.4%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 47 47 $37,600 $6,795 18.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 33 33 $13,365 $5,740 42.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 18 18 $24,300 $3,708 15.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 23 23 $6,555 $3,295 50.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 17 17 $13,600 $2,988 22.0%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 13 13 $10,400 $2,427 23.3%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 208 259 $142,450 $23,577 16.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 212 286 $41,470 $20,324 49.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 139 139 $45,870 $18,607 40.6%

About Dr. Ronald Roth, MD

Dr. Ronald Roth, MD is a Gastroenterology healthcare provider based in Tavares, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013105253.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Roth, MD has received a total of $1,071 in payments from pharmaceutical and medical device companies, with $18.24 received in 2024. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,071).

As a Medicare-enrolled provider, Roth has provided services to 3,856 Medicare beneficiaries, totaling 4,373 services with total Medicare billing of $452,556. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Tavares, FL
  • Active Since 10/12/2007
  • Last Updated 10/12/2007
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1013105253

Products in Payments

  • Epclusa (Drug) $198.00
  • GED-0301 (Drug) $137.89
  • XARELTO (Drug) $119.36
  • ELIQUIS (Drug) $99.00
  • Prolia (Biological) $99.00
  • BYVALSON (Drug) $95.51
  • INVOKANA (Drug) $86.89
  • AVYCAZ (Drug) $84.77
  • Reveal LINQ (Device) $56.30
  • SPRIX (Drug) $40.80
  • ZOHYDRO ER (Drug) $34.93
  • Cologuard Collection Kit (Device) $18.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Tavares